Olmetec 20mg tablets

Țară: Regatul Unit

Limbă: engleză

Sursă: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredient activ:

Olmesartan medoxomil

Disponibil de la:

Daiichi Sankyo UK Ltd

Codul ATC:

C09CA08

INN (nume internaţional):

Olmesartan medoxomil

Dozare:

20mg

Forma farmaceutică:

Oral tablet

Calea de administrare:

Oral

Clasă:

No Controlled Drug Status

Tip de prescriptie medicala:

Valid as a prescribable product

Rezumat produs:

BNF: 02050502; GTIN: 5015494280208

Prospect

PACKAGE LEAFLET: INFORMATION FOR THE USER
(olmesartan medoxomil)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING THIS MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor
or pharmacist.

This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them,
even if their signs of illness are the same as
yours.

If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
The name of your medicine is Olmetec 20mg Tablets
but it will be referred to as Olmetec throughout this
leaflet. Please note that the leaflet also contains
information about other strengths Olmetec 10mg and
40mg Tablets.
WHAT IS IN THIS LEAFLET
1.
What Olmetec is and what it is used for
2.
What you need to know before you take Olmetec
3.
How to take Olmetec
4.
Possible side effects
5.
How to store Olmetec
6.
Contents of the pack and other information
1.
WHAT OLMETEC IS AND WHAT IT IS USED
FOR
Olmetec belongs to a group of medicines called
angiotensin-II receptor antagonists. They lower blood
pressure by relaxing the blood vessels.
Olmetec is used for the treatment of high blood
pressure (also known as ‘hypertension’) in adults and
in children and adolescents aged 6 to less than 18
years. High blood pressure can damage blood
vessels in organs such as the heart, kidneys, brain
and eyes. In some cases this may lead to a heart
attack, heart or kidney failure, stroke or blindness.
Usually high blood pressure has no symptoms. It is
important to have your blood pressure checked to
prevent damage occurring.
High blood pressure can be controlled with medicines
such as Olmetec. Your doctor has probably also
recommended that you make some changes in your
lifestyle to help lower your blood pressure (for
example losing weight, giving up smoking, reducing
the amount of alcohol you drink and reducing the
amount of salt

Caracteristicilor produsului

OBJECT 1
OLMETEC FILM-COATED TABLETS
Summary of Product Characteristics Updated 04-Oct-2017 | Daiichi
Sankyo UK Limited
1. Name of the medicinal product
Olmetec 10 mg film-coated tablets
Olmetec 20 mg film-coated tablets
Olmetec 40 mg film-coated tablets
2. Qualitative and quantitative composition
Olmesartan medoxomil
Each film-coated tablet contains 10 mg olmesartan medoxomil
Each film-coated tablet contains 20 mg olmesartan medoxomil
Each film-coated tablet contains 40 mg olmesartan medoxomil
Excipient with known effect
Olmetec 10 mg film-coated tablets: each film-coated tablet contains
61.6 mg lactose monohydrate
Olmetec 20 mg film-coated tablets: each film-coated tablet contains
123.2 mg lactose monohydrate
Olmetec 40 mg film-coated tablets: each film-coated tablet contains
246.4 mg lactose monohydrate
For the full list of excipients, see section 6.1
3. Pharmaceutical form
Film-coated tablet.
Olmetec 10 and 20 mg tablets: White, circular, film-coated tablets
with C13 and C14 respectively
embossed on one side.
Olmetec 40 mg tablets: White, oval, film-coated tablets with C15
embossed on one side.
4. Clinical particulars
4.1 Therapeutic indications
Treatment of essential hypertension in adults.
Treatment of hypertension in children and adolescents from 6 to less
than 18 years of age.
4.2 Posology and method of administration
Posology
_Adults_
The recommended starting dose of olmesartan medoxomil is 10 mg once
daily. In patients whose blood
pressure is not adequately controlled at this dose, the dose of
olmesartan medoxomil may be increased to
20 mg once daily as the optimal dose. If additional blood pressure
reduction is required, olmesartan
medoxomil dose may be increased to a maximum of 40 mg daily or
hydrochlorothiazide therapy may be
added_. _
The antihypertensive effect of olmesartan medoxomil is substantially
present within 2 weeks of initiating
therapy and is maximal by about 8 weeks after initiating therapy. This
should be borne in mind when
considering changing the dose regimen for any patient.
_Elderly